# Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis

> **NCT06269185** · — · COMPLETED · sponsor: **Vastra Gotaland Region** · enrollment: 271 (actual)

## Conditions studied

- Ulcerative Colitis
- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Infliximab
- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT06269185
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-06
- **Primary completion:** 2024-10-18
- **Final completion:** 2024-10-18
- **Target enrollment:** 271 (ACTUAL)
- **Last updated:** 2024-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06269185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06269185, "Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06269185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*